Universität zu Köln

Journal Article

Frontzek, Fabian ORCID: 0000-0003-1705-3638, Ziepert, Marita, Nickelsen, Maike, Altmann, Bettina, Glass, Bertram, Haenel, Mathias, Truemper, Lorenz, Held, Gerhard, Bentz, Martin, Borchmann, Peter, Dreyling, Martin, Viardot, Andreas, Kroschinsky, Frank P., Metzner, Bernd, Staiger, Annette M., Horn, Heike, Ott, German, Rosenwald, Andreas, Loeffler, Markus, Lenz, Georg and Schmitz, Norbert (2021). Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. Lancet Haematol., 8 (4). S. E267 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Held, Gerhard, Thurner, Lorenz, Poeschel, Viola, Berdel, Christian, Ott, German, Schmidt, Christian, Viardot, Andreas, Borchmann, Peter, Shpilberg, Ofer, Nickelsen, Maike, Federico, Massimo, Brown, Peter de Nully, Murawski, Niels, Trumper, Lorenz H., Schmidberger, Heinz, Ruebe, Christian, Fleckenstein, Jochen, Schmitz, Norbert, Loeffler, Markus, Ziepert, Marita and Alliance, German Lymphoma (2020). Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: A subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hentrich, Marcus, Berger, Marcel, Wyen, Christoph, Siehl, Jan, Rockstroh, Juergen K., Mueller, Markus, Faetkenheuer, Gerd, Seidel, Elisabeth, Nickelsen, Maike, Wolf, Timo, Rieke, Ansgar, Schuermann, Dirk, Schmidmaier, Ralf, Planker, Manfred, Alt, Juergen, Mosthaf, Franz, Engert, Andreas, Arasteh, Keikawus and Hoffmann, Christian (2012). Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study. J. Clin. Oncol., 30 (33). S. 4117 - 4124. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael (2019). Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet, 394 (10216). S. 2271 - 2282. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Borchmann, Peter, Schmidt, Christian, Viardot, Andreas, Bentz, Martin, Peter, Norma, Ehninger, Gerhard, Doelken, Gottfried, Ruebe, Christian, Truemper, Lorenz, Rosenwald, Andreas, Pfreundschuh, Michael, Loeffler, Markus and Glass, Bertram (2012). Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). Lancet Oncol., 13 (12). S. 1250 - 1260. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1470-2045

Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Viardot, Andreas, Dreyling, Martin H., Borchmann, Peter, Bokemeyer, Carsten, Peschel, Christian, Wolf, Hans-Heinrich, Mahlberg, Rolf, Pfreundschuh, Michael and Glass, Bertram (2015). Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020